Literature DB >> 23732899

Divergent contributions of regulatory T cells to the pathogenesis of chronic hepatitis C.

Ayssa A Self1, Phyllis T Losikoff, Stephen H Gregory.   

Abstract

Hepatitis C virus, a small single-stranded RNA virus, is a major cause of chronic liver disease. Resolution of primary hepatitis C virus infections depends upon the vigorous responses of CD4(+) and CD8(+) T cells to multiple viral epitopes. Although such broad CD4(+) and CD8(+) T-cell responses are readily detected early during the course of infection regardless of clinical outcome, they are not maintained in individuals who develop chronic disease. Purportedly, a variety of factors contribute to the diminished T-cell responses observed in chronic, virus-infected patients including the induction of and biological suppression by CD4(+)FoxP3(+) regulatory T cells. Indeed, a wealth of evidence suggests that regulatory T cells play diverse roles in the pathogenesis of chronic hepatitis C, impairing the effector T-cell response and viral clearance early during the course of infection and suppressing liver injury as the disease progresses. The factors that affect the generation and biological response of regulatory T cells in chronic, hepatitis C virus-infected patients is discussed.

Entities:  

Keywords:  dendritic cells; hepatitis C; immune tolerance; liver disease; regulatory T cells

Mesh:

Substances:

Year:  2013        PMID: 23732899      PMCID: PMC3974886          DOI: 10.4161/hv.24726

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  112 in total

1.  Scope of worldwide hepatitis C problem.

Authors:  Robert S Brown; Paul J Gaglio
Journal:  Liver Transpl       Date:  2003-11       Impact factor: 5.799

Review 2.  How tolerogenic dendritic cells induce regulatory T cells.

Authors:  Roberto A Maldonado; Ulrich H von Andrian
Journal:  Adv Immunol       Date:  2010       Impact factor: 3.543

3.  T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection.

Authors:  Tobias Boettler; Hans Christian Spangenberg; Christoph Neumann-Haefelin; Elisabeth Panther; Simonetta Urbani; Carlo Ferrari; Hubert E Blum; Fritz von Weizsäcker; Robert Thimme
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

4.  Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance.

Authors:  Xuefang Cao; Sheng F Cai; Todd A Fehniger; Jiling Song; Lynne I Collins; David R Piwnica-Worms; Timothy J Ley
Journal:  Immunity       Date:  2007-10-04       Impact factor: 31.745

5.  Prevalence of hepatitis C virus infection among injection drug users in the United States, 1994-2004.

Authors:  Joseph J Amon; Richard S Garfein; Linda Ahdieh-Grant; Gregory L Armstrong; Lawrence J Ouellet; Mary H Latka; David Vlahov; Steffanie A Strathdee; Sharon M Hudson; Peter Kerndt; Don Des Jarlais; Ian T Williams
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

Review 6.  Animal models for hepatitis C.

Authors:  Eva Billerbeck; Ype de Jong; Marcus Dorner; Cynthia de la Fuente; Alexander Ploss
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

7.  Hepatitis C virus induces regulatory T cells by naturally occurring viral variants to suppress T cell responses.

Authors:  Matthew F Cusick; Jennifer J Schiller; Joan C Gill; David D Eckels
Journal:  Clin Dev Immunol       Date:  2010-12-06

8.  The intestinal microbiota and viral susceptibility.

Authors:  Julie K Pfeiffer; Justin L Sonnenburg
Journal:  Front Microbiol       Date:  2011-04-27       Impact factor: 5.640

9.  Analysis of successful immune responses in persons infected with hepatitis C virus.

Authors:  F Lechner; D K Wong; P R Dunbar; R Chapman; R T Chung; P Dohrenwend; G Robbins; R Phillips; P Klenerman; B D Walker
Journal:  J Exp Med       Date:  2000-05-01       Impact factor: 14.307

10.  Massive peptide sharing between viral and human proteomes.

Authors:  Darja Kanduc; Angela Stufano; Guglielmo Lucchese; Anthony Kusalik
Journal:  Peptides       Date:  2008-06-05       Impact factor: 3.750

View more
  4 in total

1.  Report from the field: Overview of the Sixth Annual Vaccine Renaissance Conference.

Authors:  Denice Spero; Lauren Levitz; Anne S De Groot
Journal:  Hum Vaccin Immunother       Date:  2013-05-31       Impact factor: 3.452

Review 2.  Regulatory T-Cells at the Interface between Human Host and Pathogens in Infectious Diseases and Vaccination.

Authors:  Mardi C Boer; Simone A Joosten; Tom H M Ottenhoff
Journal:  Front Immunol       Date:  2015-05-11       Impact factor: 7.561

3.  The two-faced T cell epitope: examining the host-microbe interface with JanusMatrix.

Authors:  Leonard Moise; Andres H Gutierrez; Chris Bailey-Kellogg; Frances Terry; Qibin Leng; Karim M Abdel Hady; Nathan C VerBerkmoes; Marcelo B Sztein; Phyllis T Losikoff; William D Martin; Alan L Rothman; Anne S De Groot
Journal:  Hum Vaccin Immunother       Date:  2013-04-12       Impact factor: 3.452

4.  Smarter vaccine design will circumvent regulatory T cell-mediated evasion in chronic HIV and HCV infection.

Authors:  Leonard Moise; Frances Terry; Andres H Gutierrez; Ryan Tassone; Phyllis Losikoff; Stephen H Gregory; Chris Bailey-Kellogg; William D Martin; Anne S De Groot
Journal:  Front Microbiol       Date:  2014-10-06       Impact factor: 5.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.